Indrayani Biotech Complete Financial Statements
INDRANIB • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Indrayani Biotech (INDRANIB).
Downloads include all available records across all periods.
For market performance, see the
INDRANIB stock price today
.
Profitability Ratios
Net Profit Margin
2.63%
2025 data
EBITDA Margin
10.53%
2025 data
Operating Margin
7.00%
2025 data
Return on Assets
0.37%
2025 data
Return on Equity
1.37%
2025 data
Balance Sheet Ratios
Current Ratio
2.70
2025 data
Debt to Equity
3.67
2025 data
Equity Ratio
27.24%
2025 data
Asset Turnover
0.14
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+22.6%
Year-over-Year
EBITDA Growth
-20.0%
Year-over-Year
Expense Growth
+30.8%
Year-over-Year
Assets Growth
+14.0%
Year-over-Year
Equity Growth
-3.9%
Year-over-Year
Liabilities Growth
+14.0%
Year-over-Year
Operating Cash Flow Growth
-287.5%
Year-over-Year
Investing Cash Flow Growth
+66.0%
Year-over-Year
Financing Cash Flow Growth
+33.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38 | 53 | 30 | 31 | 45 | 32 | 17 | 41 | 51 | 42 | 39 | 44 | 17 | 26 | 46 | 15 | 7 | 14 | 15 | 5 | 14 | 4 | 6 |
| Expenses | 34 | 54 | 27 | 26 | 34 | 26 | 14 | 33 | 46 | 40 | 36 | 37 | 15 | 23 | 41 | 13 | 10 | 13 | 13 | 4 | 14 | 9 | 7 |
| EBITDA | 4 | 0 | 3 | 5 | 11 | 6 | 3 | 7 | 5 | 3 | 4 | 7 | 2 | 3 | 5 | 2 | -2 | 1 | 2 | 1 | 1 | -5 | -1 |
| Operating Profit Margin % | 7.00% | -6.00% | 7.00% | 17.00% | 23.00% | 19.00% | 17.00% | 18.00% | 6.00% | 6.00% | 9.00% | 12.00% | 13.00% | 12.00% | 12.00% | 11.00% | -36.00% | 7.00% | 12.00% | 13.00% | 6.00% | -159.00% | -20.00% |
| Depreciation | 1 | 10 | 1 | 3 | 1 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 2 | -2 | 2 | 1 | 6 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | -8 | 0 | 1 | 5 | 1 | 0 | 6 | 2 | 0 | 1 | 5 | 2 | 2 | 3 | 1 | -3 | 1 | 1 | 0 | 0 | -5 | -2 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | -9 | 0 | 1 | 5 | 1 | 0 | 6 | 1 | 0 | 1 | 5 | 2 | 2 | 3 | 1 | -3 | 1 | 1 | 0 | 0 | -5 | -2 |
| Earnings Per Share (₹) | 0.09 | -1.42 | 0.03 | 0.13 | 0.58 | 0.10 | 0.05 | 0.89 | 0.32 | -0.06 | 0.22 | 1.47 | 0.47 | 0.52 | 0.72 | 0.30 | -0.92 | 0.20 | 0.33 | 0.03 | 0.08 | -1.57 | -0.51 |
Related Pages for Indrayani Biotech
Additional stock information and data for INDRANIB
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 268 | 235 | 156 | 51 | 40 | 52 |
| Current Assets | 178 | 145 | 78 | 19 | 9 | 19 |
| Fixed Assets | 60 | 62 | 58 | 17 | 15 | 17 |
| Capital Work in Progress | 26 | 20 | 14 | 13 | 14 | 14 |
| Investments | 41 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 152 | 85 | 22 | 11 | 21 |
| LIABILITIES | ||||||
| Total Liabilities | 268 | 235 | 156 | 51 | 40 | 52 |
| Current Liabilities | 66 | 72 | 36 | 7 | 8 | 7 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 73 | 76 | 48 | 25 | 20 | 31 |
| Share Capital | 46 | 46 | 44 | 34 | 34 | 4 |
| Reserves & Surplus | 27 | 18 | 10 | -10 | -15 | -3 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|
| Operating Activities | -30 | 16 | 4 | 0 | 6 |
| Investing Activities | -16 | -47 | -1 | -1 | -4 |
| Financing Activities | 44 | 33 | -3 | 0 | -1 |
| Net Cash Flow | -3 | 2 | 1 | -1 | 1 |